NCT03061227View on ClinicalTrials.gov

Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge

NACompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

January 17, 2019

Study Completion Date

April 30, 2020

Conditions
Metabolic SyndromeDiabetes
Interventions
DRUG

Intravenous glucagon

Randomized application of glucagon or saline during oral glucose tolerance test

DRUG

Intravenous saline

Randomized application of glucagon or saline during oral glucose tolerance test

Trial Locations (1)

72076

University Hospital Tübingen, Tübingen

All Listed Sponsors
lead

University Hospital Tuebingen

OTHER

NCT03061227 - Characterization of Metabolic and Brain Effects of Rising Glucagon During an Oral Glucose Challenge | Biotech Hunter | Biotech Hunter